Infectious agents in coronary atheromas: A possible role in the pathogenesis of plaque rupture and acute myocardial infarction

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 44, Issue 4, 2002, Pages 217-224

  Higuchi, Maria De Lourdes ^a   Ramires, Jose A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Infection; Mycoplasma pneumoniae; Myocardial infarction; Vulnerable plaque

Indexed keywords

CHLAMYDIASIS; CORONARY ARTERY ATHEROSCLEROSIS; HEART INFARCTION; HUMAN; MICROBIOLOGY; MYCOPLASMA PNEUMONIA; PATHOLOGY; REVIEW; RUPTURE;

CHLAMYDIA INFECTIONS; CORONARY ARTERIOSCLEROSIS; HUMANS; MYOCARDIAL INFARCTION; PNEUMONIA, MYCOPLASMA; RUPTURE, SPONTANEOUS;

EID: 0036651530     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652002000400007     Document Type: Review

References (32)

1. ALMAGOR, M.; KAHANE, I. & YATZIV, S. - Role of superoxide anion in host cell injury induced by M. pneumoniae infection. A study in normal and trisomy 21 cells. J. clin. Invest., 73: 842-847, 1984.
2. BEZERRA, H.G.; HIGUCHI, M.L.; GUTIERREZ, P.S. et al. - Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargment. Cardiovasc. Path., 10: 189-196, 2001.
3. BOYLE, J.J. - Association of coronary plaque rupture and atherosclerotic inflammation. J. Path., 181: 93-99, 1997.
4. CLARKSON, T.B.; PRICHARD, R.W.; MORGAN, T.M.; PETRICK, G.S. & KLEIN, K.P. - Remodeling of coronary arteries in human and nonhuman primates. J. Amer. med. Ass., 271: 289-294, 1994.
5. ERICSON, K.; SALDEEN, T.G.P.; LINDQUIST, O.; PAHLSON, C. & MEHTA, J.L. -Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation, 101: 2568-2571, 2000.
6. GALLILY, R.; AVRON, A.; JAHNS-STREUBEL, G. & MUHLRADT, P.F. - Activation of macrophages and monocytes by mycoplasmas. In: RAZIN, S. & TULLY, J.G., ed. Molecular and diagnostic procedures in mycoplasmology. vol. I. Molecular characterization. San Diego, Academic Press, 1995. p. 421-438.
7. GLADER, C.A.; BOMAN, J.; SAIKKU, P. et al. - The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies. Europ. Heart J., 21: 639-646, 2000.
8. GLAGOV, S.; WEISENBERG, E.; ZARINS, C.K.; STANKUNAVICIUS, R. & KOLETTIS, G.J. - Compensatory enlargement of human atherosclerotic coronary arteries. New Engl. J. Med., 316: 1371-1375, 1987.
9. GUPTA, S. - Chronic infection in the etiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis, 143: 1-6, 1999.
10. HIGUCHI, M.L.; BEZERRA, H.G.; PALOMINO, S. et al. - Adventitial fibrosis and inflammation surrounding atheroma: implications for different arterial remodeling in stable and unstable plaques. J. Amer. Coll. Cardiol., 35: 368A, 2000.
11. HIGUCHI, M.L.; GUTIERREZ, P.S.; BEZERRA, H.G. et al. - Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq. bras. Cardiol., 79: 20-24, 2002.
12. HIGUCHI, M.L.; CASTELLI, J.B.; AIELLO, V.D. et al. - Great amount of C. pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study of stable plaques. Arq. bras. Cardiol., 74: 149-151, 2000.
13. HIGUCHI, M.L.; SAMBIASE, N.; PALOMINO, S. et al. - Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz. J. med. biol. Res., 33: 1023-1026, 2000.
14. HOFFMEISTER, A.; ROTHENBACHER, D.; WANNER, P. et al. - Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case - control study. J. Amer. Coll. Cardiol., 35: 112-118, 2000.
15. KUO, C. & CAMPBELL, L.A. - Detection of Chlamydia pneumoniae in arterial tissues. J. infect. Dis., 181(suppl. 3): S432-S436, 2000.
16. LEINONEN, M. & SAIKKU, P. - Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Amer. Heart J., 138: S504-S506, 1999.
17. LIBBY, P.; GENG, Y.J.; AIKAWA, M. et al. - Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol., 7: 330-335, 1996.
18. MAASS, M.; BARTELS, C.; KRÜGER, S. et al. - Endovascular presence of C. pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis, 140(suppl. 1): S25-S30, 1998.
19. NISHIOKA, T.; LUO, H.; EIGLER, N.L. et al. - Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J. Amer. Coll. Cardiol., 27: 1571-1576, 1996.
20. OPITZ, O.; PIETSCH, K.; EHLERS, S. & JACOBS, E. - Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology, 196: 575-587, 1997.
21. RAZIN, S.; YOGEV, D. & NAOT, Y. - Molecular biology and pathogenicity of mycoplasmas. Microbiol. molec. Biol. Rev., 62: 1094-1156, 1998.
22. ROSS, R. - Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340: 115-126, 1999.
23. SAIKKU, P.; LEINONEN, M.; MATTILA, K. et al. - Serologic evidence of an association of a novel Chlamydia TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet, 2: 983-986, 1988.
24. SHOENFELD, Y.; SHERER, Y. & HARATS, D. - Atherosclerosis. An infectious, inflammatory and autoimmune disease. Trends in Immunology. (http://news.bmn.com/ hmsbeagle/102/notes/feature12)
25. SHOR, A. & PHILLIPS, J.I. - Chlamydia pneumoniae and atherosclerosis. J. Amer. med. Ass., 282: 2071-2073, 1999.
26. SMITS, P.C.; BOS, L.; QUARLES VAN UFFORD, M.A. et al. - Shrinkage of human coronary arteries is an important determinant of de novo atherosclerotic luminal stenosis: an in vivo intravascular ultrasound study. Heart, 79: 143-147, 1998.
27. SMITS, P.C.; PASTERKAMP, G.; JAEGERE, P.P.T.; FEYTER, P.J. & BORST, C. -Angioscopic complex lesions are predominatly compensatory enlarged: an angioscopy and intracoronary ultrasound study. Cardiovasc. Res., 41: 458-464, 1999.
28. STACEY, A. &. BRADLOW, A. - Arcanobacterium haemolyticum and Mycoplasma pneumoniae co-infection. J. Infect., 38: 41-42, 1999.
29. THOMAS, M.; WONG, Y.; THOMAS, D. et al. - Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation, 99: 2733-2736, 1999.
30. VAN DER WAL, A.C.; PIEK, J.J.; DE BOER, O.J. et al. - Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart, 80: 14-18, 1998.
31. WANISHSAWAD, C.; ZHOU, Y.F. & EPSTEIN, S.E. - Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis. J. infect. Dis., 181: 787-790, 2000.
32. WONG, Y.; THOMAS, M.; TSANG, V.; GALLAGHER, P.J. & WARD, M.E. - The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery. J. Amer. Coll. Cardiol., 33: 152-156, 1999.